The research follows a KFF Health Tracking Poll in May in which 12% of adults reported taking a GLP-1 drug at some point. Six percent said they are currently using one. There are a variety of GLP ...

FDA mandates GLP-1 drug label updates for kidney injury risk due to dehydration, urging caution for users with gastrointestinal issues.

No GLP-1 agonists are inside these patches — they’re herbal and vitamin blends, not pharmaceuticals. There’s no proven weight-loss effect because patch delivery can’t match doses achieved ...

GLP-1 drugs may protect the brain from inflammation, some studies say, but others warn they may increase depression risk. Image credit: James Manning – PA Images/Getty Images.

Compounded GLP-1s helped people continue treatment while brand-name GLP-1 injections were in shortage. But they’re not meant to be a long-term solution when FDA-approved options are available.

Explore the growing GLP-1 agonists market, driven by rising diabetes and obesity rates. Discover advancements in therapies like Tirzepatide and GZR18, offering both glycemic control and weight ...

A study by the Evernorth Research Institute looking at national prescription drug use trends found GLP-1 use between 2023-2024 rose 84.6% in Gen Alpha (ages 14 and younger). The age group was ...

Direct-to-consumer pharmaceutical startup Hims & Hers Health said it is selling injectable GLP-1 weight loss drugs for a fraction of the cost of brand-name competitors such as Wegovy and Ozempic.

Over three years of follow-up between 2020 and 2023, 0.2% (93 patients) of those in the GLP-1 user group were diagnosed with nAMD, as were 0.1% (88 patients) in the contrasting group.

The takeaway GLP-1 medications are highly effective for weight management and type 2 diabetes management. These medications may have both positive and negative effects on the gastrointestinal tract.